1Hu Z, Fan C, Oh DS, et al. The molecular portraits of breast tumors are conserved across microarray platforms [ J ]. BMC Ge- nomics, 2006,7 (7) :96.
2Anders CK, Carey LA. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer[ J]. Clin Breast Canc- er, 2009,9( suppl 2) :$73-$81.
3Kim MJ, Ro JY, Ahn SH, et al. Clinicopathologic sig,.aificance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotype [ J ]. Hum Pathol, 2006,37(9) :1217-1226.
4Sasa M, Bando Y, Takahashi M, et al. Screening for basal marker expression is necessary for decision of therapeutic strategy for triple- negative breast cancer[J]. J Surg Oncol, 2008,97( 1 ) :30-34.
5Tumer NC, Reis-Filho JS, Russell AM, et al. BRCA1 dysfunction in sporadic bgsal-like breast cancer [ J ]. Oncogene, 2007,26 (14) :2126-2132.
6Carey LA, Pereu CM, Livasy CA, et al. Race, breast cancer sub- types, and survival in the Carolina Breast Cancer Study [ J ]. JA- MA, 2006,295(21 ) :2492-2502.
7Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer [J]. N Engl J Med, 2009,360(8) :790-800.
8Korsching E, Jeffrey SS, MeinerzrW, et al. Basal carcinoma of the breast revisited : an old entity with new interpretations [ J ]. J Clin Pathol, 2008,61 (5) :553-560.
9Mallon E, Osin P, Nasiri N, et al. The basic pathology of human breast cancer[ J ]. Mammary Gland Bid Neoplasia, 2000,5 ( 2 ) : 139-163.
10Kaplan HG, Malmgren JA, Atwood MK. T1N0 triple negative breast cancer: adjuvant chemotherapy treatment and risk of recur- rence [ J ]. Breast J, 2009,15 (5) :454-460.
6Sugg SL, Furguson DJ, Posner, MC, et al. Should internal mamn- lary nodes be sampled in the sentinel lymph node era [ J 1. Surg Oneol, 2010,7 ( 3 ) : 188-192.
7Yao MS, Kurland BF, Smith AH, et al. Internal mammary nodal chain drainage is a prognostic indicator in axillary node positive breast cancer[J]. Ann Surg Oneol, 2011,14(10) :2985-2993.
8Cranenbroek S, vander Sangen MJ, Kuijt GP, et al. Diagnosis, treatment and progaaosis of internal mammary lymph node recur- rence in breast cancer patients [ J ] . Breast Cancer Res Treat, 2010,89(3) :271-275.
9Singletary SE, Allred C, Ashley P, et al. Revision of the american joint committee on cancer staging system for breast cancer [ J ]. J Clin Oncol, 2012,20 (17) :3628-3636.
10Huang O, Wang L, Shen K, et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis : analysis of 2269 Chinese breast cancer patients treated with extended radical mastectomy [ J 1- Breast Cancer Res Treat, 2008,107 (3) : 379- 387.
